Skip Navigation LinksHome > February 2012 - Volume 32 - Issue 1 > A Randomized, Naturalistic, Parallel-Group Study for the Lon...
Journal of Clinical Psychopharmacology:
doi: 10.1097/JCP.0b013e31823fe4bd
Brief Reports

A Randomized, Naturalistic, Parallel-Group Study for the Long-Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Nardi, Antonio E. MD, PhD*; Freire, Rafael C. MD, MSc*; Mochcovitch, Marina D. MD*; Amrein, Roman MD*; Levitan, Michelle N. MSc*; King, Anna L. MSc*; Valença, Alexandre M. MD, PhD*†; Veras, André B. MD, MSc*; Paes, Flávia MSc*; Sardinha, Aline MSc*; Nascimento, Isabella MD, PhD*; de-Melo-Neto, Valfrido L. MD, MSc*‡; Dias, Gisele P. MSc*; e Silva, Adriana Cardoso de O. PhD*†; Soares-Filho, Gastão L. MD, MSc; da Costa, Rafael T. MSc*; Mezzasalma, Marco A. MD, PhD*; de Carvalho, Marcele R. MSc*; de Cerqueira, Ana C. MD, MSc*; Hallak, Jaime E. MD, PhD; Crippa, José A. MD, PhD; Versiani, Marcio MD, PhD*

Collapse Box


Abstract: This long-term extension of an 8-week randomized, naturalistic study in patients with panic disorder with or without agoraphobia compared the efficacy and safety of clonazepam (n = 47) and paroxetine (n = 37) over a 3-year total treatment duration. Target doses for all patients were 2 mg/d clonazepam and 40 mg/d paroxetine (both taken at bedtime). This study reports data from the long-term period (34 months), following the initial 8-week treatment phase. Thus, total treatment duration was 36 months. Patients with a good primary outcome during acute treatment continued monotherapy with clonazepam or paroxetine, but patients with partial primary treatment success were switched to the combination therapy. At initiation of the long-term study, the mean doses of clonazepam and paroxetine were 1.9 (SD, 0.30) and 38.4 (SD, 3.74) mg/d, respectively. These doses were maintained until month 36 (clonazepam 1.9 [SD, 0.29] mg/d and paroxetine 38.2 [SD, 3.87] mg/d). Long-term treatment with clonazepam led to a small but significantly better Clinical Global Impression (CGI)–Improvement rating than treatment with paroxetine (mean difference: CGI-Severity scale −3.48 vs −3.24, respectively, P = 0.02; CGI-Improvement scale 1.06 vs 1.11, respectively, P = 0.04). Both treatments similarly reduced the number of panic attacks and severity of anxiety. Patients treated with clonazepam had significantly fewer adverse events than those treated with paroxetine (28.9% vs 70.6%, P < 0.001). The efficacy of clonazepam and paroxetine for the treatment of panic disorder was maintained over the long-term course. There was a significant advantage with clonazepam over paroxetine with respect to the frequency and nature of adverse events.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.